Canbank Venture Capital Fund
VC Fund
Bangalore, India
Canbank Venture Capital Fund is a VC fund in Bangalore focused on Medical and Health Care. Canbank Venture is a premier domestic Venture Capital Fund. An experienced fund management company, Canbank Venture believes in adopting a General Fund philosophy and has a good portfolio of investments in several promising sectors.The fund's corpus is contributed by Public Sector Banks and Financial Institutions and Insurance Companies.Over the last 20 Years Canbank Venture has invested in several promising companies, partnered progress and posted successful exits.We invest in businesses with an established technological or market positioning edge and good growth potential. The company has a well qualified team to invest, manage and create value in its investee companies.Canbank Venture shall be investing from Emerging India Growth Fund (EIGF). EIGF is a Close Ended, Domestic & General Fund set up to achieve long term capital appreciation from equity and equity related investments in a broad based portfolio of well established Indian companies managed by professional teams
- Total investments:
- 6
- Last investment:
- Lead investor:
- 83%
Last updated:
For AI agents: llms.txt
Industries Canbank Venture Capital Fund invests in
Stages Canbank Venture Capital Fund invests in
Countries Canbank Venture Capital Fund invests in
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- B2B 1 (17%)
- Rental 1 (17%)
- Chatbot 1 (17%)
Stage
- Seed 3 (50%)
- Venture - Series Unknown 2 (33%)
- Series A 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Qube Health
|
Qube Health is a health tech company, focused on the ‘Employee Healthcare Management’ vertical. Qube Health provides primary care, health screening, and other ‘non-insurance healthcare services’ to large companies across six different industries including, financial services, food services, facility management, and manufacturing. | Seed / Nov 05, 2024 | |
CoRover
|
CoRover is a Conversational AI Chatbot Platform with proprietary cognitive AI technology. It is delivered as a Managed Service. Traction: 200 million+ users. 4 million+ DAU. 500,000 concurrent users.Contextually: Highest traction in India, 2.5x nearest competitor. CoRover’s top 3 competitive advantages are:1. Versatility: Multi-format -video, voice, text Omni-channel - Web, App, WhatsApp, IVR, SMS, Social Media Bots) and Multilingual - works with 12 vernacular & 100 foreign languages2. Tech Edge: Robust, Secure, Scalable Architecture (>500K concurrent users supported) Designed grounds up to be deployed on public / private clouds and on premise. 3. Turnaround Time: 10x quicker to deploy, thanks to ease of training with our proprietary patent pending CBML (ChatBot Markup Language) technology. Train the bot in English and make it available in any language with industry leading (>95%) accuracy. | $4M / Series A / Sep 24, 2024 | |
Koovers
|
Koovers assures workshops of spares with ease of ordering, doorstep delivery, genuine and complete basket of parts of all car makers | $1M / Seed / Jun 17, 2022 | |
Renalyx Health Systems
|
Renalyx Health Systems is a health care company specializing in comprehensive renal care, and dialysis treatment. | Venture - Series Unknown / Feb 02, 2022 | |
Settlrs
|
Settlrs is a rental services company for furniture, home appliances, electronic and IT infrastructure. | $940.3K / Seed / Jan 20, 2022 | |
|
CoRover
|
CoRover is a Conversational AI Chatbot Platform with proprietary cognitive AI technology. It is delivered as a Managed Service. Traction: 200 million+ users. 4 million+ DAU. 500,000 concurrent users.Contextually: Highest traction in India, 2.5x nearest competitor. CoRover’s top 3 competitive advantages are:1. Versatility: Multi-format -video, voice, text Omni-channel - Web, App, WhatsApp, IVR, SMS, Social Media Bots) and Multilingual - works with 12 vernacular & 100 foreign languages2. Tech Edge: Robust, Secure, Scalable Architecture (>500K concurrent users supported) Designed grounds up to be deployed on public / private clouds and on premise. 3. Turnaround Time: 10x quicker to deploy, thanks to ease of training with our proprietary patent pending CBML (ChatBot Markup Language) technology. Train the bot in English and make it available in any language with industry leading (>95%) accuracy. | Venture - Series Unknown / Jul 06, 2021 |
Co-Investors
Astarc Ventures
1 deal together
Cogniphy
1 deal together
IIM Calcutta Innovation Park
1 deal together
IIT Delhi Endowment Fund
1 deal together
Inflection Point Ventures
1 deal together
JN Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Canbank Venture Capital Fund invest in?
Canbank Venture Capital Fund invests primarily in Medical, Health Care and B2B startups, most often at Seed and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Canbank Venture Capital Fund last invest?
The most recent investment recorded for Canbank Venture Capital Fund closed in Nov 2024. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
